Amicus Therapeutics
FOLD
#3310
Rank
C$6.41 B
Marketcap
C$20.43
Share price
0.00%
Change (1 day)
94.63%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2023 (TTM): C-$0.87

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.16. In 2022 the company made an earnings per share (EPS) of C-$1.16 an increase over its 2021 EPS that were of C-$1.30.

EPS history for Amicus Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$0.87-25.17%
2022C-$1.16-10.87%
2021C-$1.30-14.02%
2020C-$1.51-29.14%
2019C-$2.13-18.82%
2018C-$2.621.64%
2017C-$2.5822%
2016C-$2.1126.05%
2015C-$1.6827.96%
2014C-$1.31-19.13%
2013C-$1.625.5%
2012C-$1.54-15.5%
2011C-$1.82-35.18%
2010C-$2.81610.71%
2009C-$0.39-83.91%
2008C-$2.45-86.15%
2007C-$17.72-85.97%
2006C-$126.3282.72%
2005C-$69.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
C$5.75-3,806.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
C$3.33-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$4.06-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
C-$0.21 36.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02820-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.54-445.45%๐Ÿ‡บ๐Ÿ‡ธ USA